Literature DB >> 7833564

Pediatric HIV infection: neurologic and neuropsychologic findings.

M G Fowler1.   

Abstract

Neurologic and neuropsychologic findings are early and important prognostic indicators of symptomatic HIV disease among infants and young children. The most common presentations include progressive encephalopathy, loss of motor milestones, and corticospinal tract abnormalities. It is hypothesized that, in some instances, the more severe neurologic manifestations of HIV noted in infancy may reflect the consequences of in utero HIV infection, or the increased vulnerability of infants to HIV infection during a time of rapid brain growth. Current research suggests that infants with basal ganglia calcification and those with plummeting or low CD4+ counts are at particular risk of severe central nervous disease progression. In contrast to infants and toddlers, older children and adolescents appear to demonstrate only subtle neurologic dysfunction until very late in their illness. Findings seen include attentional difficulties, fine motor tremors, visual sequencing problems, and depressive affect. One of the challenges for the 1990s will be rapidly to identify those infants who are at high risk of central nervous system disease progression, and to institute effective treatments that can halt the devastating effects of HIV on the developing brain. In addition to early identification of the high-risk infants, neuropsychologic, neuroimaging and laboratory measures need to be identified that will allow effective monitoring of responses to therapy.

Entities:  

Mesh:

Year:  1994        PMID: 7833564     DOI: 10.1111/j.1651-2227.1994.tb13337.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  5 in total

1.  Correlating brain volume and callosal thickness with clinical and laboratory indicators of disease severity in children with HIV-related brain disease.

Authors:  Savvas Andronikou; Christelle Ackermann; Barbara Laughton; Mark Cotton; Nicollette Tomazos; Bruce Spottiswoode; Katya Mauff; John M Pettifor
Journal:  Childs Nerv Syst       Date:  2014-05-23       Impact factor: 1.475

2.  Corpus callosum thickness on mid-sagittal MRI as a marker of brain volume: a pilot study in children with HIV-related brain disease and controls.

Authors:  Savvas Andronikou; Christelle Ackermann; Barbara Laughton; Mark Cotton; Nicollette Tomazos; Bruce Spottiswoode; Katya Mauff; John M Pettifor
Journal:  Pediatr Radiol       Date:  2015-01-27

Review 3.  HIV-1 proteins, Tat and gp120, target the developing dopamine system.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

4.  Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study.

Authors:  Sylvia Fitting; Rosemarie M Booze; Ulla Hasselrot; Charles F Mactutus
Journal:  Hippocampus       Date:  2010-04       Impact factor: 3.899

5.  White matter signal abnormalities in children with suspected HIV-related neurologic disease on early combination antiretroviral therapy.

Authors:  Christelle Ackermann; Savvas Andronikou; Barbara Laughton; Martin Kidd; Els Dobbels; Steve Innes; Ronald van Toorn; Mark Cotton
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.